These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 6324597)

  • 21. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
    Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
    N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The corticotropin-releasing hormone stimulation test in chronic schizophrenia.
    Roy A; Pickar D; Doran A; Wolkowitz O; Gallucci W; Chrousos G; Gold P
    Am J Psychiatry; 1986 Nov; 143(11):1393-7. PubMed ID: 3022612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pseudo-Cushing syndrome. Physiopathologic aspects and differential diagnosis].
    Ceroni L; Cota D; Pasquali R
    Minerva Endocrinol; 2000 Jun; 25(2):47-54. PubMed ID: 11189791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Corticotropin releasing factor as an aid in the diagnosis of Cushing syndrome].
    Pirich K; Vierhapper H; Nowotny P
    Wien Klin Wochenschr; 1985 Nov; 97(21):806-8. PubMed ID: 2998101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice.
    Stenzel-Poore MP; Cameron VA; Vaughan J; Sawchenko PE; Vale W
    Endocrinology; 1992 Jun; 130(6):3378-86. PubMed ID: 1597149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of hypothalamic-pituitary-adrenal suppression following curative surgery for Cushing's syndrome due to adrenal adenoma.
    Gordon D; Semple CG; Beastall GH; Thomson JA
    Acta Endocrinol (Copenh); 1987 Feb; 114(2):166-70. PubMed ID: 3030034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence against changes in corticotroph CRF receptors in depressed patients.
    Young EA; Akil H; Haskett RF; Watson SJ
    Biol Psychiatry; 1995 Mar; 37(6):355-63. PubMed ID: 7772643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corticotropin releasing hormone: clinical endocrinology and implications for Cushing's disease and endogenous depression.
    Jaeckle RS; Lopez JF
    Psychiatr Med; 1985; 3(2):111-34. PubMed ID: 3037611
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs.
    Gold PW; Licinio J; Wong ML; Chrousos GP
    Ann N Y Acad Sci; 1995 Dec; 771():716-29. PubMed ID: 8597444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hypothalamic-pituitary-adrenal axis in anorexia nervosa.
    Licinio J; Wong ML; Gold PW
    Psychiatry Res; 1996 Apr; 62(1):75-83. PubMed ID: 8739117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Corticotropin releasing factor (CRF): diagnostic aspects].
    Müller OA; Stalla GK; von Werder K
    Internist (Berl); 1985 May; 26(5):251-8. PubMed ID: 2989206
    [No Abstract]   [Full Text] [Related]  

  • 34. Corticotropin-releasing factor (CRF)--a review.
    Emeric-Sauval E
    Psychoneuroendocrinology; 1986; 11(3):277-94. PubMed ID: 3538110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin, Cushing's disease, and depression.
    Sonino N; Fava GA
    Psychother Psychosom; 1996; 65(2):63-5. PubMed ID: 8711083
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interrelation of disorders in gonadotropin and prolactin secretion and the activity of the hypothalamo-hypophyseal-adrenal system in Itsenko-Cushing disease].
    Manusharova RA; Cheban AK; Komissarenko IV; Slavnov VN; Veĭnberg EG
    Probl Endokrinol (Mosk); 1984; 30(4):31-5. PubMed ID: 6089167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
    Isidori AM; Kaltsas GA; Korbonits M; Pyle M; Gueorguiev M; Meinhardt A; Metz C; Petrovsky N; Popovic V; Bucala R; Grossman AB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1834-40. PubMed ID: 11932327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disorders of the hypothalamic-pituitary-adrenal axis.
    Wand GS; Ney RL
    Clin Endocrinol Metab; 1985 Feb; 14(1):33-53. PubMed ID: 2990779
    [No Abstract]   [Full Text] [Related]  

  • 40. Maternal and environmental factors influence the hypothalamic-pituitary-adrenal axis response to corticotropin-releasing hormone infusion in offspring of mothers with or without mood disorders.
    Ronsaville DS; Municchi G; Laney C; Cizza G; Meyer SE; Haim A; Radke-Yarrow M; Chrousos G; Gold PW; Martinez PE
    Dev Psychopathol; 2006; 18(1):173-94. PubMed ID: 16478558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.